301. Correction to: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association.
作者: Joseph C Wu.;Donna K Arnett.;Ivor J Benjamin.;Mark A Creager.;Robert A Harrington.;Joseph A Hill.;P Michael Ho.;Steven R Houser.;Stephanie Scarmo.;Svati H Shah.;Gordon F Tomaselli.; .
来源: Circulation. 2025年151卷14期e919页 304. Correction to: Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration-Tobacco Working Group.
作者: Zhiqi Yao.;Erfan Tasdighi.;Zeina A Dardari.;Kunal K Jha.;Ngozi Osuji.;Tanuja Rajan.;Ellen Boakye.;Carlos J Rodriguez.;Kunihiro Matsushita.;Eleanor M Simonsick.;Joao A C Lima.;Rachel Widome.;Debbie L Cohen.;Lawrence J Appel.;Amit Khera.;Michael E Hall.;Suzanne Judd.;Shelley A Cole.;Ramachandran S Vasan.;Emelia J Benjamin.;Aruni Bhatnagar.;Andrew P DeFilippis.;Michael J Blaha.
来源: Circulation. 2025年151卷14期e922页 305. Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
作者: Heather L Gornik.;Herbert D Aronow.;Philip P Goodney.;Shipra Arya.;Luke Packard Brewster.;Lori Byrd.;Venita Chandra.;Douglas E Drachman.;Jennifer M Eaves.;Jonathan K Ehrman.;John N Evans.;Thomas S D Getchius.;J Antonio Gutiérrez.;Beau M Hawkins.;Connie N Hess.;Karen J Ho.;W Schuyler Jones.;Esther S H Kim.;Scott Kinlay.;Lee Kirksey.;Debra Kohlman-Trigoboff.;Chandler A Long.;Amy West Pollak.;Saher S Sabri.;Lawrence B Sadwin.;Eric A Secemsky.;Maya Serhal.;Mehdi H Shishehbor.;Diane Treat-Jacobson.;Luke R Wilkins.
来源: Circulation. 2025年151卷14期e918页 306. Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES.
作者: P Gabriel Steg.;Michael Szarek.;J Wouter Jukema.;Deepak L Bhatt.;Vera A Bittner.;Rafael Diaz.;Sergio Fazio.;Geneviève Garon.;Shaun G Goodman.;Robert A Harrington.;Harvey D White.;Andreas M Zeiher.;Gregory G Schwartz.; .
来源: Circulation. 2025年151卷14期1047-1050页 308. Racial Disparities in Long-Term Outcomes After Endovascular Aortic Aneurysm Repair in Black and White Medicare Beneficiaries.
作者: Abena Appah-Sampong.;Christina Marcaccio.;Siling Li.;Yang Song.;Mohamad A Hussain.;Robert Yeh.;Marc L Schermerhorn.;Eric A Secemsky.
来源: Circulation. 2025年
Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic aneurysmal intervention, there is a paucity of literature aimed at understanding long-term disparities. The present study aims to characterize racial disparities in long-term outcomes, perioperative outcomes, and health care use after endovascular aortic aneurysm repair.
309. Long-Term Trajectories of Left Heart Geometry, Mechanics, and Oxygen Demand After Bariatric Surgery.
作者: Lisa M D Grymyr.;Saied Nadirpour.;Eva Gerdts.;Bjørn G Nedrebø.;Knut Matre.;Dana Cramariuc.
来源: Circ Heart Fail. 2025年18卷5期e012367页
The long-term impact of bariatric surgery on cardiac mechanics and energetics has been scarcely documented. We aimed to assess prospectively the 5-year trajectories of left heart geometry, mechanics, and myocardial oxygen (O2) demand after bariatric surgery.
310. Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
作者: Tiffany M Powell-Wiley.;LaPrincess C Brewer.;Lora E Burke.;Rosalba Hernandez.;Jill Landsbaugh Kaar.;Maura Kepper.;Christopher E Kline.;Keila N Lopez.;Shamarial Roberson.;Colleen K Spees.;Gerald J Jerome.; .
来源: Circulation. 2025年151卷18期e972-e985页
Populations most affected by cardiovascular health disparities, including underrepresented populations with lower socioeconomic status, people with disabilities, and those living in underserved rural communities, are disproportionately exposed to adverse social determinants of health. Specifically, economic instability and suboptimal living conditions within the neighborhood and built environment directly determine access to resources and opportunities for healthful behaviors. In this scientific statement, we examined the technology-enabled interventions that address cardiovascular health behaviors from adolescence to adulthood in populations most affected by health disparities. We used a broad definition of technology, including wearables, applications, and telehealth, for behavior tracking. Aligning with Life's Essential 8, we focused on interventions targeting behavior change related to physical activity, sedentary time, dietary intake, tobacco cessation, and sleep health to improve cardiovascular health. The digital determinants of health are important adjuncts to the social determinants and operate at the individual, interpersonal, community, and societal levels. The digital determinants of health include the impact of digital technologies (eg, wearables, telemedicine) across health outcomes. Evidence of effective interventions using technology to improve cardiovascular health through positive behavior change is critical for preventing cardiovascular disease events. Stronger evidence is needed to inform and implement effective approaches that are scalable and cost-effective across communities and health care institutions to advance digital equity in cardiovascular health. Dissemination of digital solutions to improve cardiovascular health in communities or across health care systems must ensure effective, feasible, available, and affordable solutions for populations most in need.
311. Effect of a Meal on Invasive Hemodynamics and Plasma Incretin Levels in Patients With Heart Failure.
作者: Tania Deis.;Kasper Rossing.;Mads Ersbøll.;William Herrik Nielsen.;Birthe Henriksen.;Bolette Hartmann.;Jens Juul Holst.;Caroline Kistorp.;Marat Fudim.;Jens Peter Goetze.;Palle Bekker Jeppesen.;Finn Gustafsson.
来源: Circ Heart Fail. 2025年18卷5期e012630页
The importance of gastrointestinal hormones, including the incretins glucagon-like peptide-1 (GLP-1) and GIP (glucose-dependent insulinotropic polypeptide), in heart failure pathophysiology is debated. The postprandial incretin response and its relation to hemodynamic changes in patients with heart failure, however, remains unknown.
312. Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac Damage.
作者: Philippe Généreux.;Björn Redfors.;Philippe Pibarot.;Brian R Lindman.;Gennaro Giustino.;Alissa Dratch.;Shannon Murphy.;Soumya Chikermane.;Martin B Leon.;Suzanne J Baron.
来源: Circ Cardiovasc Interv. 2025年18卷5期e014945页
The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aortic valve replacement (AVR). However, the association between the extent of cardiac damage at the time of AVR and health care costs and resource utilization has never been described.
314. Comparing Cardiovascular Mortality Estimates From Global Burden of Disease and From the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research.
作者: Abdul Mannan Khan Minhas.;Sadeer Al-Kindi.;Harriette G C Van Spall.;Dmitry Abramov.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷5期e011459页
Several sources of data, including the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) and the Global Burden of Disease (GBD) data set, report causes of mortality in the United States. While CDC WONDER contains data based on death certificate codes, the GBD mortality data undergo additional processing, such as cause-of-death reassignment before reporting. Potential differences in reported mortality from cardiovascular disease in the United States between these 2 data sources have not been characterized.
316. Incidence, Prevalence, and Trends in Mortality and Stroke Among Medicare Beneficiaries With Atrial Fibrillation: 2013 to 2019.
作者: Nichole M Rogovoy.;Stephen Kearing.;Weiping Zhou.;James V Freeman.;Jonathan P Piccini.;Sana M Al-Khatib.;Emily P Zeitler.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷5期e011365页
Atrial fibrillation (AF) is known to be associated with increased risks of stroke and death, but contemporary studies of this association are lacking. We evaluated trends in stroke and death among Medicare beneficiaries with AF between 2013 and 2019.
317. Impact of In-Hospital Quality of Care Improvement Initiative on Secondary Prevention of Acute Coronary Syndrome in Six Months After Patient Discharge: A Large Stepped Wedge- and Cluster-Randomized Controlled Trial.
作者: Gaoqiang Xie.;Anushka Patel.;Xin Du.;Yihong Sun.;Xian Li.;Tao Wu.;Zhixin Hao.;Runlin Gao.;Yangfeng Wu.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷5期e011441页
Patients discharged after acute coronary syndrome experience a high risk of major adverse cardiovascular events (MACE) within the first 6 months. We examined whether a quality of care improvement initiative implemented in hospitals affects clinical preventive management and outcomes after discharge.
318. Reserve and Resilience: A Framework to Inform Cardiovascular Disease Outcomes Research Among Older Adults.
作者: Ene M Enogela.;C Barrett Bowling.;Emily B Levitan.;Monika M Safford.;Madeline R Sterling.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷5期e011396页 319. Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
作者: Arisa Sittichokkananon.;Victoria Garfield.;Scott T Chiesa.
来源: Circulation. 2025年151卷17期1235-1247页
Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. We examined whether an increased genetic risk for CAD is associated with long-term risk of developing all-cause, Alzheimer's, or vascular dementia, and investigated whether differences in potentially modifiable lifestyle factors in the mid- to late-life period may attenuate this risk.
320. Review of the Global Activity of Heart Transplant.
作者: Abdelghani El Rafei.;Rebecca Cogswell.;Fernando A Atik.;Andreas Zuckermann.;Larry A Allen.
来源: Circ Heart Fail. 2025年e012272页
Heart failure is a global disease with significant morbidity. Heart transplant (HT) can be a lifesaving therapy for select patients with end-stage heart failure. In 2020, over 7000 HTs were performed globally; 90% of HTs were performed in the United States and Western Europe, with only 10% throughout the rest of the world. In this article, we offer an overview of the global landscape of HT, exploring challenges and prospects worldwide. We review HT practices, rates and post-HT outcomes, underscoring the differences between countries within each region. We review limitations hindering HT expansion, such as sociocultural factors, as seen in Japan and Israel; health care funding, in countries like India and South Africa; socioeconomic disparities in access, like the United States; and shortage in organ supply, as seen in China and Saudi Arabia. This review underscores the need to address limitations and highlights opportunities to enhance global HT accessibility, especially in lower- and middle-income countries.
|